Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue International Journal of Pharmaceutics Année : 2017

Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR

Résumé

Like several 50 nm-large nanocarriers, lipid nanoparticles (LNPs) can passively accumulate in tumors through the Enhanced Permeability and Retention effect. In this study, we developed PEGylated LNPs loaded with IR780 iodide as a contrast agent for NIR fluorescence imaging and modified them with cyclic RGD peptides in order to target integrin αvβ3. We demonstrate a specific targeting of the receptor with cRGD-LNPs but not with cRAD-LNP and standard LNP using HEK293(β3), HEK293(β3)-αvRFP, DU145 and PC3 cell lines. We also demonstrate that cRGD-LNPs bind to αvβ3, interfere with cell adhesion to vitronectin and co-internalize with αvβ3 within one hour. We then investigated their biodistribution and tumor targeting in mice bearing DU145 or M21 tumors. We observed no significant differences between cRGD-LNP and the non-targeted ones regarding their biodistribution and accumulation/retention in tumors. This suggested that despite an efficient formulation of the cRGD-LNPs, the cRGD-mediated targeting was not increasing the total amount of LNP that can already accumulate passively in the subcutaneous tumors via the Enhanced Permeability and Retention effect (EPR).

Domaines

Cancer
Fichier principal
Vignette du fichier
Jungyoon Choi Int J Parm_Revised (1).pdf (3.09 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-01488572 , version 1 (13-03-2017)

Identifiants

Citer

Jungyoon Choi, Emilie Rustique, Maxime Henry, Mélanie Guidetti, Véronique Josserand, et al.. Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR. International Journal of Pharmaceutics, 2017, [Epub ahead of print]. ⟨10.1016/j.ijpharm.2017.03.007⟩. ⟨inserm-01488572⟩
302 Consultations
407 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More